Enter your email address:

Delivered by FeedBurner

COVID-19 highlighted vulnerabilities in medical manufacturing supply chain: Fitch

"We believe that over the longer term, govt may aim to source more key
pharmaceutical ingredients locally as opposed to the current heavy
reliance on China, and to a lesser degree India," it said. This
provides an opportunity for the Indian govt to escalate domestic
production of pharma ingredients to counteract an over-reliance on
Chinese imports now hampered by COVID-19 shutdowns.



Post a Comment